DK2714042T3 - En analgetisk farmaceutisk sammensætning til oral administration - Google Patents
En analgetisk farmaceutisk sammensætning til oral administrationInfo
- Publication number
- DK2714042T3 DK2714042T3 DK12735347.2T DK12735347T DK2714042T3 DK 2714042 T3 DK2714042 T3 DK 2714042T3 DK 12735347 T DK12735347 T DK 12735347T DK 2714042 T3 DK2714042 T3 DK 2714042T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical composition
- oral administration
- analgesic pharmaceutical
- analgesic
- oral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL39506911A PL395069A1 (pl) | 2011-05-31 | 2011-05-31 | Przeciwbólowa kompozycja farmaceutyczna do podawania doustnego |
| PCT/PL2012/050016 WO2012165985A1 (en) | 2011-05-31 | 2012-05-31 | An analgesic pharmaceutical composition for oral administration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2714042T3 true DK2714042T3 (da) | 2019-01-02 |
Family
ID=46513810
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK12735347.2T DK2714042T3 (da) | 2011-05-31 | 2012-05-31 | En analgetisk farmaceutisk sammensætning til oral administration |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9101577B2 (da) |
| EP (1) | EP2714042B1 (da) |
| DK (1) | DK2714042T3 (da) |
| ES (1) | ES2708689T3 (da) |
| HU (1) | HUE040419T2 (da) |
| PL (2) | PL395069A1 (da) |
| WO (1) | WO2012165985A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160022594A1 (en) * | 2013-03-15 | 2016-01-28 | Russell Jaffe | Soft gel encapsulation |
| GB2607333A (en) * | 2021-06-03 | 2022-12-07 | Horopito Ltd | Pain relief composition |
| EP4389120A1 (en) * | 2022-12-20 | 2024-06-26 | Inflacod Sp. z o.o. | An anti-inflammatory pharmaceutical composition |
| WO2026033410A1 (en) * | 2024-08-05 | 2026-02-12 | Vm1 Spolka Z Ograniczona Odpowiedzialnoscia | Analgesic dosage form for oral administration with abuse-deterrent properties |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020051794A1 (en) * | 2000-08-09 | 2002-05-02 | Alk-Abello A/S | Novel parenteral vaccine formulations and uses thereof |
| EP1408902A4 (en) * | 2001-06-22 | 2008-02-13 | Millard Marsden Mershon | COMPOSITIONS AND METHODS FOR REDUCING LIQUID AND BLOOD LOSS FROM OPEN WOUNDS |
| DE60224056T2 (de) * | 2001-08-27 | 2008-12-04 | Kyowa Chemical Industry Co. Ltd., Takamatsu | Antazide und laxative magnesiumoxid-tablette |
| US20040048870A1 (en) * | 2002-09-06 | 2004-03-11 | Amir Ahmad A. | Composition for the prevention and treatment of migraine headaches |
| AU2004229464A1 (en) * | 2003-04-08 | 2004-10-28 | Progenics Pharmaceuticals, Inc. | Combination therapy for constipation comprising a laxative and a peripheral opioid antagonist |
| US20070259033A1 (en) * | 2003-09-26 | 2007-11-08 | Evangeline Cruz | Controlled release formulations exhibiting an ascending rate of release |
| US20080220064A1 (en) * | 2006-12-06 | 2008-09-11 | Ramesh Ketkar Anant | Extended release matrix formulations of morphine |
-
2011
- 2011-05-31 PL PL39506911A patent/PL395069A1/pl unknown
-
2012
- 2012-05-31 PL PL12735347T patent/PL2714042T3/pl unknown
- 2012-05-31 ES ES12735347T patent/ES2708689T3/es active Active
- 2012-05-31 HU HUE12735347A patent/HUE040419T2/hu unknown
- 2012-05-31 WO PCT/PL2012/050016 patent/WO2012165985A1/en not_active Ceased
- 2012-05-31 DK DK12735347.2T patent/DK2714042T3/da active
- 2012-05-31 EP EP12735347.2A patent/EP2714042B1/en active Active
- 2012-05-31 US US14/122,712 patent/US9101577B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2708689T3 (es) | 2019-04-10 |
| HUE040419T2 (hu) | 2019-03-28 |
| EP2714042B1 (en) | 2018-08-29 |
| PL2714042T3 (pl) | 2019-03-29 |
| US9101577B2 (en) | 2015-08-11 |
| US20140127302A1 (en) | 2014-05-08 |
| PL395069A1 (pl) | 2012-12-03 |
| WO2012165985A1 (en) | 2012-12-06 |
| EP2714042A1 (en) | 2014-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2680832T3 (da) | Vandig farmaceutisk formulering af tapentadol til oral administration | |
| DK2632493T3 (da) | Lægemiddelindgivelsessammensætninger | |
| SMT201500232B (it) | Dispositivo per la somministrazione de farmaci | |
| DK3527241T3 (da) | Indretning til administration af lægemiddel | |
| LT2817000T (lt) | Peroralinės dabigatrano eteksilato farmacinės kompozicijos | |
| CO6852076A2 (es) | Composiciones farmacéuticas inhalables | |
| DK2694038T3 (da) | Farmaceutisk sammensætning | |
| BR112013017169A2 (pt) | composições farmacêuticas de ferro para administração oral | |
| BR112014003052A2 (pt) | composições farmacêuticas | |
| DK3284467T3 (da) | Nikotinholdige farmaceutiske sammensætninger | |
| IL229409B (en) | Intranasal pharmaceutical dosage forms comprising naloxone | |
| HUE046748T2 (hu) | Orális beadásra szánt kortikoszteroid készítmények | |
| EP2629786A4 (en) | COMPOSITIONS FOR THE ADMINISTRATION OF MEDICAMENTS | |
| EP2758052A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| CO6950486A2 (es) | Solución para administración oral | |
| CO6940426A2 (es) | Formulaciones farmacéuticas | |
| BR112013012476A2 (pt) | formulações farmacêuticas contendo corticosteróides para administração tópica | |
| DK2542224T3 (da) | Oral farmaceutisk sammensætning indeholdende dabigatranetexilat | |
| BRPI1007484A2 (pt) | composição farmacêutica para administração oral | |
| DK2815752T3 (da) | Oral farmaceutisk sammensætning | |
| HUE039907T2 (hu) | Gyógyszer-szállító technológia | |
| EP2769718A4 (en) | MEDICAL COMPOSITION | |
| BR112014015885A8 (pt) | preparação farmacêutica | |
| SMT201500005B (it) | Composizione framaceutica inalabile | |
| CU24163B1 (es) | Composición farmacéutica oftalmológica tópica que contiene regorafenib |